13. 多発性硬化症／視神経脊髄炎 Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details

臨床試験数 : 3,342 / 薬物数 : 2,355 - (DrugBank : 406) / 標的遺伝子数 : 269 - 標的パスウェイ数 : 241

5 trials found

diseases per page:

Showing 1 to 5 of 5 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03368664 (ClinicalTrials.gov)	October 24, 2017	2/11/2017	A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRM ...	A Multi-center, Open-label, Single-arm, Before and After Switch Study to Evaluate the Efficacy, Safe ...	Multiple Sclerosis	Drug: Alemtuzumab GZ402673;Drug: Glatiramer acetate;Drug: Beta-Interferon;Drug: Methylprednisolone;Dru ...	Genzyme, a Sanofi Company	NULL	Active, not recruiting	10 Years	17 Years	All	50	Phase 3	Austria;Belgium;France;Italy;Netherlands;Poland;Portugal;Russian Federation;Turkey;United Kingdom;Bu ...
2	EUCTR2013-002378-26-SE (EUCTR)	13/11/2014	15/08/2013	Switch To RItuXimab in MS extensionAn extension study of an ongoing clinical trial where people with ...	Switch To RItuXimab in MS extensionAn extension study of STRIX-MS - a phase 2 open label study of Ri ...	The original trial (EudraCT 2010-023021-38) recruited 74 patients with relapsing-remitting multiple ...	Trade Name: Mabthera ® Product Name: Mabthera	Västerbottens Läns Landsting	NULL	Not Recruiting			Female: yes Male: yes	74	Phase 2	Sweden
3	EUCTR2010-023021-38-SE (EUCTR)	23/02/2011	26/11/2010	Switch To RItuXimab in MSA phase 2 open label study of Rituximab in MS patients previously treated w ...	Switch To RItuXimab in MSA phase 2 open label study of Rituximab in MS patients previously treated w ...	Relapsing-remitting multiple sclerosis in stable condition while treated with first line injectible ...	Trade Name: Mabthera INN or Proposed INN: RITUXIMAB	Västerbottens läns landsting	NULL	Not Recruiting			Female: yes Male: yes		Phase 2	Sweden
4	NCT01049451 (ClinicalTrials.gov)	November 2009	13/1/2010	Pulse ACTH vs. MP for MS	Comparison of Monthly Pulse ACTH (Acthar Gel) Therapy With Methylprednisolone (MP, Solumedrol) for L ...	Multiple Sclerosis	Drug: ACTH;Drug: Methylprednisolone	University of Southern California	NULL	Completed	18 Years	65 Years	All	23	Phase 1	United States
5	EUCTR2008-000955-90-IT (EUCTR)	24/04/2007	12/03/2008	Randomized, single-blind, clinical and MRI study for evaluation of safety and efficacy of N-Acetyl C ...	Randomized, single-blind, clinical and MRI study for evaluation of safety and efficacy of N-Acetyl C ...	multiple sclerosis MedDRA version: 9.1;Level: HLT;Classification code 10052785;Term: Multiple sclero ...	Product Name: n-acetylcysteine INN or Proposed INN: Acetylcysteine	ISTITUTO C. MONDINO	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			Italy

First Previous1Next Last